Abstract
Virulence plasmids are associated with hypervirulent types of Klebsiella pneumoniae, which generally do not carry antibiotic resistance genes. In contrast, nosocomial isolates are often associated with resistance, but rarely with virulence plasmids. Here, we describe virulence plasmids in nosocomial isolates of “high-risk” clones of sequence types (STs) 15, 48, 101, 147 and 383 carrying carbapenemase genes. The whole genome sequences were determined by long-read nanopore sequencing. The 12 isolates all contained hybrid plasmids containing both resistance and virulence genes. All carried rmpA/rmpA2 and the aerobactin cluster, with the virulence plasmids of two of three representatives of ST383 carrying blaNDM-5 and seventeen other resistance genes. Representatives of ST48 and ST15 had virulence plasmid-associated genes distributed between two plasmids, both containing antibiotic resistance genes. Representatives of ST101 were remarkable in all sharing virulence plasmids in which iucC and terAWXYZ were missing and iucB and iucD truncated. The combination of resistance and virulence in plasmids of high-risk clones is extremely worrying. Virulence plasmids were often notably consistent within a lineage, even in the absence of epidemiological links, suggesting they are not moving between types. However, there was a common segment containing multiple resistance genes in virulence plasmids of representatives of both STs 48 and 383.
Keywords: virulence plasmid, rmpA/rmpA2, carbapenemase, high-risk clone, Klebsiella pneumoniae, nanopore sequencing
1. Introduction
Klebsiella pneumoniae poses a dual threat to human health; in the community, it is associated with invasive disease, which can affect young, otherwise healthy people, while in the nosocomial setting it has a marked propensity to acquire antibiotic resistance [1,2,3]. It is unusual for isolates to display both these properties, but, increasingly, resistant and virulent isolates have been reported [4,5,6]. Traditionally, “hypervirulence” has been associated only with particular types, such as capsular type K1 sequence type (ST) 23 (K1-ST23) and capsular type K2 ST86 (K2-ST86), which were generally susceptible to antibiotics, but recently, virulence elements found in these types have also been described in other STs that are strongly associated with resistance, such as STs 11, 15 and 383 [7,8,9,10]. Many of these elements are carried on a large virulence plasmid, which typically carries acquired siderophore genes (especially for aerobactin, but also for salmochelin and enterochelin), heavy metal resistance genes (coding for tellurite, silver, copper and lead resistance) and capsule up-regulation genes, rmpA and rmpA2. We have previously described a representative of ST147 carrying blaNDM-1 which carried a hybrid virulence plasmid that not only contained the aerobactin cluster, rmpA, rmpA2, and tellurite resistance genes, but also the antibiotic resistance genes sul1, sul2, armA, dfrA5, mph(A), and aph(3′)-VIb (CM007852) [9]. Similarly, Lam et al. [11] have described representatives of ST15 carrying both virulence and resistance genes in a single plasmid, and a virulence plasmid carrying blaKPC-2 was reported in K1 hypervirulent Klebsiella pneumoniae [12]. In such cases, selection by relevant antibiotics will also select for virulence characteristics. Sequencing of further carbapenemase-gene-positive nosocomial isolates has identified twelve more isolates carrying hybrid resistance/virulence plasmids, three carrying a plasmid containing both blaNDM-5 and virulence genes, which we describe here.
2. Results
KpvST101_OXA-48 was isolated in June 2018 from blood from an elderly patient with septicaemia in a hospital in South East England. Typing by VNTR analysis gave a profile of 5,4,1,1,-,2,4,4,3,2,3, corresponding to ST101, confirmed from the whole genome sequence. A blaOXA-48-like gene was detected by PCR, as were rmpA and rmpA2. The minION sequencing gave a number of fully circularised contigs corresponding to the chromosome (5453528 bp) (CP031368), the IncL/M OXA-48 plasmid (65380 bp) (CP031374) and the virulence plasmid (292699 bp) (CP031369), among others. The IncFII(K)/IncFIB(K) virulence plasmid contained rmpA, rmpA2, the aerobactin cluster (iutA, iucABD, although both iucB and iucD were truncated), copper (pcoABCDERS), silver (silCERS) and tellurite (terBCDE) resistance genes, other genes associated with hypervirulence (notably cobW, involved in cobalamin biosynthesis, luxR, coding for a quorum-sensing regulator controlling virulence gene expression, pagO, which protects bacteria from phagocytosis, shiF, promoting transfer of lysine) and antibiotic resistance genes aph(6)-Id (conferring resistance to streptomycin), blaTEM-1B (beta-lactam resistance), mph(A) (macrolide resistance), sul1, sul2 (sulphonamide resistance) and dfrA5 (trimethoprim resistance) (Table 1, Figure 1a). Interestingly, this isolate carried pld1, coding for a phospholipase D family protein, which has been linked to hypervirulence [13], as well as the yersiniabactin cluster (irp1, irp2, ybtAEPQSTUX) in the chromosome, which also carried genes encoding resistance to beta-lactam antibiotics, fluoroquinolones and fosfomycin. It was resistant to most antibiotics tested (including amikacin, gentamicin, tobramycin, ampicillin, aztreonam, cefepime, cefotaxime, ceftazidime, ertapenem, piperacillin/tazobactam, temocillin, ceftolozane/tazobactam, ciprofloxacin and minocycline), with the exception of imipenem, colistin and ceftazidime/avibactam; there was reduced susceptibility to meropenem (MIC 8 mg/L) (Table S1). All the resistance genes detected are listed in Table 1. Two other isolates of rmpA/rmpA2-positive ST101 were sequenced, one isolated in May 2018 from a further patient from the same hospital as KpvST101_OXA-48 (Kpv_ST101_SE2_2), and the other (Kpv_ST101_L5) isolated in October 2018 from a patient in a London hospital with no known epidemiological links to the other two. Remarkably, all three isolates had virulence plasmids lacking iucC and terAWXYZ (but containing terBCDE) and carrying truncated iucB and iucD; these are the only isolates in which this has been observed (Figure 1a–c). There were fewer resistance genes in the virulence plasmid of the London isolate (mph(A), sul1, dfrA5 only) than in the other two ST101 isolates, which both carried the same complement of additional genes (Table 1). All three isolates had additional plasmids carrying blaOXA-48.
Table 1.
Isolate | Virulence Plasmid | Other Virulence Factors (Chromosome) | Antibiotic Genes in Virulence Plasmid | Other Resistance Genes | Hospital (Code), Date and Source of Isolation | Clinical Manifestation | Comments |
---|---|---|---|---|---|---|---|
KpvST101_OXA-48 Illumina corrected sequence | plasmid pKpvST101 CP031369 292699 bp rmpA, rmpA2, (iutA, iucABD, (iucB and iucD truncated), pcoABCDERS, silCERS terBCDE, cobW, luxR, pagO, shiF | fyuA, kfuABC, irp1, irp2, ybtAEPQSTUX, mrkABCDFHIJ, pld1 | aph(6)-Id, aph(3’)-Ib, blaTEM-1Bmph(A), sul1, sul2 and dfrA5 | Chromosome blaSHV-28, blaCTX-M-15, oqxA, oqxB, fosA plasmid CP031374 65380 bp blaOXA-48 plasmid CP031372 210661 bp armA, msr(E), mph(E) plasmid CP031373 43670 bp blaSHV-28, qnrS1 | South_East_2 (SE2) June 2018 blood | septicaemia | no iucC no terAWXYZ |
Kpv_ST101_SE2_2 | utg000004c (294751 bp) iutA, iucABD (iucB and iucD truncated), rmpA, rmpA2, terBCDE, pcoABCDERS, silCERS, FecA, cobW, luxR, pagO, shiF | fyuA, kfuABC, irp1, irp2, ybtAEPQSTUX, pld1, mrkABCDFHIJ | aph(6)-Id, aph(3’)-Ib, blaTEM-1B, mph(A), sul1, sul2 and dfrA5 | Chromosome blaSHV-28, blaCTX-M-15, oqxA, oqxB, fosA, utg16c; 65307 bp blaOXA-48 utg31c blaCTX-M-15, armA, msr(E), mph(E) utg27c blaSHV-28, qnrS1 | South_East_2 (SE2) May 2018 sputum | chest infection | no iucC no terAWXYZ |
Kpv_ST101_L5 | utg00035c (267754 bp) iutA, iucABD (iucB and D truncated), rmpA, rmpA2, terBCDE, pcoABCDERS, silCERS, FecA, cobW, luxR, pagO, shiF | fyuA, irp1, irp2, kfuABC, ybtAEPQSTUX, pld1, mrkABCDFHIJ | mph(A), sul1, dfrA5 | Chromosome blaSHV-28, blaCTX-M-15, oqxA, oqxB, fosA utg000020c armA, msr(E), mph(E) utg000037c blaOXA-48 utg000108c blaSHV-28, qnrS1 | London_5 (L5) October 2018 rectal screen | screen | no iucC no terAWXYZ |
KpvST383_NDM_OXA-48 Illumina corrected sequence | plasmid pKpvST383L CP034201 372826 bp iutA, iucABCD, rmpA/rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF | mrkABCDFHIJ, pld1 | blaNDM-5, blaCTXM-15, blaOXA-9, qnrS1, blaTEM-1B, dfrA5, catA1, sul1, sul2, armA, aph(3′)-1a, aph(3′)-VI, aac(6′)-lb, aadA1, aac(6′)-lb-cr, mph(A), mph (E) and msr(E) | blaSHV-26, oqxA, oqxB, fosA, mph(A), catA1, tet(A) plasmid CP034202 72057 bp aph(6)-Id, aph(3’)-Ib, aph(3’)-VIb, aph(3’)-Ib, blaCTX-M-14b, blaOXA-48 | London_5 (L5) April 2018 blood | bacteraemia, sepsis, multi-organ failure and death | no yersiniabactin |
Kpv_ST383_L2 | utg000003c (294,141) iutA, iucABCD, rmpA/rmpA2, terABCDEWZ, cobW, luxR, pagO, shiF | mrkABCDFHIJ, pld1 | aph(3’)-Ia, aadA1, sul1, tet(B) | blaSHV-26, oqxA, oqxB, fosA, sul1 utg000002c (110455 bp) rmtC, blaNDM-1 utg000011c (105957 bp) aph(’’)-Ib, aph(6)-Id, aac(6’)-Ib3, aadA1, blaOXA-48 blaCTX-M-14b, blaOXA-9, aac(6’)-Ib-cr | London_2 (L2) April 2017 blood | sepsis | Not got yersiniabactin ybt cluster, irp1,2) or terXY |
Kpv_ST383_S1 | utg000038c (374430 bp) (pKpvST383_S1) iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, pagO, shiF, luxR | mrkABCDFHIJ, pld1 | aadA1, aac(6’)-Ib aph(3’)-Ia, armA, aph(3’)-VI, blaTEM-1B, blaOXA-9, blaCTX-M-15, blaNDM-5, aac(6’)-Ib-cr, qnrS1, msr(E), mph(E), mph(A), catA1, sul1, sul2, dfrA5 | blaSHV-26, oqxA, oqxB, fosA, mph(A), catA1, tet(A) utg000039c (72122 bp) aph(3’)-Ib, aph(3’)-VIb, aph(3’)-Ib, aph(6)-Id, blaOXA-48, blaCTX-M-14b | Scotland1 (S1) Feb 2016 rectal swab | No information; screening swab | terXY present, no ybt irp1,2 cluster Ex Egypt (in hospital in Cairo) |
KpvST147L_NDM previously described [9]; Illumina corrected | plasmid pKpvST147L CM007852.1 343,282 bp iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF | mrkABCDFHIJ | sul1, sul2, armA, dfrA5, mph(A), msr(E), mph(E), aph(3’)-Ia | blaNDM-1, aph(3’)-Ia. aac(6’)-Ib, aadA1 blaTEM-1A, blaOXA-9, blaCTX-M-15, blaSHV-67, qnrS1, aac(6’)-Ib-cr, oqxA, oqxB, fosA | London_5 (L5) January 2016 rectal swab | screening swab | |
KpvST147B_SE1_1_NDM Illumina corrected sequence | plasmid pKpvST147B CP040726 (339117 bp) iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF | fyuA, mrkABCDFHIJ, irp1, irp2, ybtAEPQSTUX | sul1, sul2, armA, dfrA5, mph(A), msr(E), mph(E) blaCTX-M-15 | aac(6’)-Ib, aadA1, blaSHV-67, blaOXA-9, blaTEM-1A, oqxA oqxB, aac(6’)-Ib-cr fosA plasmid CP040728 53950 bp aac(6’)-Ib-cr, aph(3’)-VI, blaOXA-1, blaCTX-M-15, blaNDM-1, qnrS1, catB3, ARR-3, sul1 | South_East_1 (SE1) January 2019 rectal swab | no information, screening swab | |
Kpv_ST147_SE1_2 Illumina corrected sequence | utg000005c (338588 bp) iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF | fyuA, mrkABCDFHIJ, irp1, irp2, ybtAEPQSTUX | armA, mphA, sul1, sul2, dfrA5, blaCTX-M-15, mph(E), msr(E) | Chromosome oqxA, oqxB, fosA, blaSHV-67 utg000020c; 53949 bp, blaNDM-1, sul1, aph(3’)-VI, catB3, ARR-3, qnrS1, aac(6’)-Ib-cr, blaOXA-1 utg000007c 39671 bp aadA1, aac(6’)-Ib, blaTEM-1A, blaOXA-9, aac(6’)-Ib-cr | South_East_1 (SE1) December 2018 urine | patient died | |
Kpv_ST147_L3 | utg000005c (339641 bp) iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF | fyuA, mrkABCDFHIJ, irp1, irp2, ybtAEPQSTUX | armA, aph(3’)-Ia, blaCTX-M-15, mph(A), mph(E), msr(E), sul1, sul2, dfrA5 | Chromosome blaSHV-67, oqxA, oqxB, fosA utg000004c; 53895 bp blaNDM-1, aac(6’)-Ib-cr, aph(3’)-VI, blaOXA-1, blaCTX-M-15, aac(6’)-Ib-cr, qnrS1, catB3, ARR-3, sul1 | London_3 (L3) January 2019 not given | No information | |
Kpv_ST15_NDM (L6) Illumina corrected sequence | plasmid pKpvST15 CP040595 277162 bp iutA, iucABCD, rmpA, rmpA2, pbrABCR, pcoABCDERS, silCERS, cobW, shiF | fyuA, irp1, irp2, ybtAEPQSTUX, kfuABC, mrkA(B), | aac(6’)-Ib3, rmtC, blaCMY-6, aac(6’)-Ib-cr, sul1 | blaCTX-M-15, blaSHV-28, oqxA, oqxB, fosA, plasmid CP040598 106597 bp blaNDM-1, sul1 | London_6 (L6) 19.12.16 Throat swab | screen | mrkB truncated (17% only), no mrkCDFHIJ, no tellurite resistance genes, pagO or luxR |
Kpv_ST15_NW1 | utg000104c (340,126 bp): iutA, iucABCD, rmpA, rmpA2, terABCDEWXYZ, cobW, luxR, pagO, shiF 2nd plasmid: utg000031c 222308 bp: pcoABCDERS, silCERS | irp1, irp2, mrkABCDFHIJ, ybtAEPQSTUX, kfuABC | armA, aph(3’)-Ia, msr(E), mph(E), mph(A), sul1, sul2, dfrA5 utg000031c: blaSHV-1, tet(D) | aph(3’)-VI, blaNDM-1, blaSHV-28, qnrS1 (utg000030l), oqxA, oqxB (utg000001l), | North_West_1 (NW1) September 2018 urine | No information | pcoABCDERS, silCERS, tet(D) in 2nd plasmid |
Kpv_ST48_NDM Illumina corrected sequence | plasmid pKpvST48_1 CM016731 302,220 bp iutA, iucABCD, rmpA, rmpA2, cobW, luxR, pagO, shiF 2nd plasmid KpvST48_2 CM016732 226800 bp pcoABCDERS, silCERS, FecA | mrkABCDFHIJ, irp1, irp2, ybtAEPQSTUX, fyuA | CM016731: aph(3’)-Ia aph(3’)-VI aac(6’)-Ib aadA1, blaNDM-5, blaCTX-M-15, blaOXA-9, blaTEM-1B, qnrS1, aac(6’)-Ib-cr, catA1 CM016732: tet(D) | aadA2, aph(3’)-Ia, blaSHV-172, blaCTX-M-14b, oqxA, oqxB, fosA, mph(A), sul1, dfrA12 | London_5 (L5) October 2018 rectal screen | No information; screening swab | pcoABCDERS, silCERS, FecA, tet(D) in CM016732, no tellurite resistance genes, patient ex Egypt |
KpvST383_NDM_OXA-48 was isolated in April 2018 from blood from a middle-aged patient with bacteraemia in a hospital in London. The patient suffered overwhelming sepsis and multi-organ failure, and subsequently died. This isolate had a VNTR profile of 3,1,5,2,0,2,3,3,4,2,3, corresponding to ST383, confirmed from the whole genome sequence. It was PCR-positive for rmpA, rmpA2, blaNDM-like and blaOXA-48-like. Sequencing gave several circular contigs, corresponding to the chromosome (5361371 bp) (CP034200), the OXA-48 plasmid (72057 bp) (CP034202), and a hybrid NDM/virulence plasmid (372826 bp) (CP034201). This plasmid contained the aerobactin cluster (iutA, iucABCD), rmpA/rmpA2, tellurite resistance genes terABCDEWXYZ, cobW, luxR, pagO, and shiF and resistance genes blaNDM-5, blaCTXM-15, blaOXA-9, qnrS1, blaTEM-1B, dfrA5, sul1, sul2, armA, aph(3′)-Ia, aph(3′)-VI, aac(6′)-lb, aadA1, aac(6′)-lb-cr, mph(A), mph(E), msr(E) and catA1 (all at 100% identity, with the exception of catA1 (99.11% identity)), with the resistance genes located in two distinct areas (Figure 1d). Genes conferring tetracycline resistance (tet(A)), fosfomycin resistance (fosA), quinolone resistance (oqxA, oqxB) and further beta-lactamase (blaSHV-26) genes were located on the chromosome (Table 1). The isolate did not carry the yersiniabactin cluster, often found in an integrative conjugative element (ICE) in the chromosome. In common with KpvST101_OXA-48, it carried pld1 and fyuA on the chromosome. The virulence plasmid is highly similar to that of KpvST147L_NDM (CM007852) [9], which has 99% identity with it, but only 93% coverage, this mainly being accounted for by the stretch from approximately 60,000 to 95,000 bp in this isolate, which contains blaNDM-5, aph(3′)-VI, qnrS1, blaCTX-M-15, aac(6′)-Ib, aac(6’)-Ib-cr, aadA1, blaOXA-9 and blaTEM-1B, missing in KpvST147L_NDM. There is an IS26-like element (also referred to as IS6 family transposase) at nucleotides (nt) 66471 to 67174, and a partial copy at 90579 to 90949, among other instances of this and other insertion sequences and transposons in the sequence (Figure 2). Two further rmpA/rmpA2-positive isolates of ST383 were sequenced, separated in space and time from KpvST383_NDM_OXA-48 (Kpv_ST383_L2, isolated in 2017 in a different London hospital, and Kpv_ST383_S1, isolated in 2016 in a Scottish hospital) (Figure 1e,f). All carried the same complement of virulence/metal resistance genes, with the exception of Kpv_ST383_L2, which lacked terXY, but, in common with the others, carried the rest of the tellurite resistance cluster (terABCDEWZ). All three lacked the yersiniabactin cluster (irp1, irp2, ybtAEPQSTUX). Kpv_ST383_NDM_OXA-48 and the Scottish isolate shared the same 18 resistance genes in the virulence plasmid, including blaNDM-5, while the second London isolate carried only aph(3’)-Ia, aadA1, sul1 and tet(B) in the virulence plasmid, the latter not found in the virulence plasmids of the other two. In contrast to the others, it carried blaNDM-1 in a separate plasmid. All three carried blaOXA-48 in a further plasmid. Essentially, KpvST383_NDM_OXA-48 and the Scottish isolate shared the same hybrid resistance/virulence plasmid, the latter sharing 99% coverage and 98.8% identity with the former (CP034201), despite being isolated over 2 years and hundreds of miles apart and with no known links between them. However, the virulence plasmid of Kpv_ST383_L2 shared only 74% coverage with that of Kpv_ST383_NDM_OXA-48. Both Kpv_ST383_L2 and Kpv_ST383_S1 were resistant to most antibiotics tested, including ceftazidime/avibactam; Kpv_ST383_L2 was susceptible to tigecycline (MIC 0.5 mg/L) and fosfomycin (MIC 32 mg/L), but resistant to colistin (MIC 32 mg/L), while Kpv_ST383_S1 was susceptible to colistin (MIC 1 mg/L) and fosfomycin (MIC 16 mg/L), but resistant to tigecycline (MIC 4 mg/L) (Table S1).
Three representatives of ST147 carrying virulence plasmids (Kpv_ST147B_SE1_1_NDM, Kpv_ST147_SE1_2, Kpv_ST147_L3) were sequenced (Table 1); in all three cases, the virulence plasmids were a similar size and carried the same virulence gene content and very similar resistance gene complements as each other and the previously described KpvST147L_NDM (CM007852) [9], despite being isolated in three different hospitals and over a three-year time span (Table 1; Figure 1g–j). There were potential epidemiological links between the three isolates described here, especially those from the same hospital, but not with the original isolate from 2016. All three isolates carried blaNDM-1 in a separate IncFIB(pQil) plasmid of approximately 54 kb (e.g., CP040728), which was highly similar between the three, supporting that they may be linked (all share 99% coverage and < 99% identity with one another; they also share similarly high homology with other NDM plasmid sequences on GenBank (e.g., AP018834); Single Nucleotide Polymorphism (SNP) analysis between the Illumina-corrected chromosomal sequences of Kpv_ST147B_SE1_1_NDM and Kpv_ST147_SE1_2 also supported this (six SNPs difference). Kpv_ST147_SE1_2 and KpvST147L_NDM were susceptible only to colistin (MICs ≤ 0.5 and 1 mg/L, respectively) (Table S1).
Kpv_ST15_NDM and Kpv_ST15_NW1 were isolated in December 2016 and September 2018 from the throat and urine of patients in hospitals in London and North West England, respectively. These representatives of ST15 displayed some considerable differences in their virulence plasmids; while both contained the aerobactin cluster (iutA, iucABCD), rmpA and rmpA2, the latter carried the tellurite resistance cluster (terABCDEWXYZ), pagO and luxR, not found in the former (Figure 1k,l). These are genes that are generally found in virulence plasmids, so their absence is notable in Kpv_ST15_NDM. Moreover, Kpv_ST15_NW1 carried the copper (pcoABCDERS) and silver (silCERS) resistance genes in a second plasmid (also carrying tet(D) and blaSHV-1), while these were carried in the virulence plasmid of Kpv_ST15_NDM (CP040595). The virulence plasmid of Kpv_ST15_NDM carried lead resistance genes (pbrABCR), not found in any of the other plasmids. Both virulence plasmids also contained a number of antibiotic resistance genes, but they were different in the two, sul1 being the only common one between them. Both isolates carried blaNDM-1 in a separate plasmid. Both carried the yersiniabactin cluster in the chromosome, but Kpv_ST15_NDM lacked some of the mrk fimbrial genes that are commonly found in K. pneumoniae and are associated with virulence. Susceptibility testing was carried out on Kpv_ST15_NDM, which was resistant to most antibiotics tested, including tigecycline and ceftazidime/avibactam, with the exception of colistin (MIC ≤ 0.5 mg/L) and fosfomycin (MIC 16mg/L) (Table S1).
The only carbapenemase-gene-positive isolate of ST48 that we have noted carrying a virulence plasmid (KpvST48_NDM) was from a patient from the same London hospital group (L5) as three other isolates in this study and was isolated in October 2018 from a rectal screen. Surprisingly, it also had the virulence and metal resistance elements associated with virulence plasmids distributed between two different plasmids. The main virulence plasmid of 302 kb (pKpvST48_1, CM016731), of type IncFIB(Mar), contained the aerobactin cluster (iutA, iucABCD), rmpA, rmpA2 and other virulence plasmid-associated genes (e.g., cobW, luxR, pagO, shiF) (Figure 1m), while the second plasmid of 226.8 kb (pKpvST48_2, CM016732) carried the lead and silver resistance gene clusters (pcoABCDERS and silCERS). Both plasmids also carried antibiotic resistance genes (aph(3’)-Ia aph(3’)-VI aac(6’)-Ib aadA1, blaNDM-5, blaCTX-M-15, blaOXA-9, blaTEM-1B, qnrS1, aac(6’)-Ib-cr, catA in the main virulence plasmid, and tet(D) in the second one). This is therefore a further example of a virulence plasmid carrying blaNDM-5 (in a different plasmid to those found in KpvST383_NDM_OXA-48/Kpv_ST383_S1); remarkably, the whole segment of pKpvST383L (CP034201 from KpvST383_NDM_OXA-48) containing antibiotic resistance genes including blaNDM-5 detailed in Figure 2 is duplicated in pKpvST48_1 (CM016731); indeed, this plasmid had 84% coverage of pKpvST383L, despite being some 70 kb smaller, including a large segment (nt 106473-283838) corresponding to nt 42544 to 220502 of pKpvST383L (CP034201), which carried the resistance genes above and ended with an IS110 family transposase.
The virulence plasmids from the representatives of “high-risk” clones were compared with one another, and with pK2044 (AP006726), the virulence plasmid from a representative of K1-ST23 (NTUH-K2044) of the KpVP-1-dominant virulence plasmid type [15] (Figure 1). This showed that all the plasmids shared virulence regions with pK2044, but that those from representatives of ST101 were quite considerably different from those of representatives of STs 147 and 383, which were very similar to one another, other than obvious differences such as the extra segment (containing blaNDM-5) in pKpvST383L (CP034201) and pKpvST383_S1 (from Kpv_ST383_S1) (Figure 1a,b) (also in pKpvST48_1). pKpvST15 (CP040595 from Kpv_ST15_NDM) was different from all the other plasmids. All the plasmids carried genes coding for plasmid transfer and various conjugal transfer proteins such as TraABDEFGIJNPUVY, suggesting that conjugative plasmid transfer is possible. Our study suggests that transfer of complete plasmids is unlikely, but that IS/transposon-bound segments of sequence containing antibiotic resistance genes may move.
In at least three of the cases described here, the isolates were associated with sepsis, supporting that they may be associated with hypervirulence. A number of others were from screening swabs; this is not a contra-indication to hypervirulence, since it is recognised that colonisation precedes infection in recognised hypervirulent types. Fortunately, the incidence of high-risk clones with virulence plasmids was still relatively low, even among submissions to the reference laboratory, which are enhanced both for carbapenemase producers and for potentially hypervirulent isolates; we have noted them since 2016, and have found a total of 40 nonduplicate isolates among some 3,600 isolates, screened up until the end of the first quarter of 2019.
3. Discussion
The high-risk clones described here (of STs 15, 48, 101, 147 and 383) are not simply gaining the virulence plasmids found in hypervirulent types, which do not generally contain antibiotic resistance genes, but carry their own versions that combine both resistance and virulence elements. The only example where a virulence plasmid in a classical hypervirulent type has been described with a resistance gene at the time of writing is the hybrid KPC-2 virulence plasmid in a hypervirulent isolate of K1-ST23, which has a conserved virulence plasmid similar to those found in other isolates of K1-ST23, but with an antibiotic resistance region flanked by two copies of IS26 [12]. The authors concluded that multiple insertion elements (IS) were responsible for mediating the plasmid recombination. Analysis by Lam et al. [16] of the virulence/resistance plasmid in our previously described representative of the high-risk clone ST147, KpvST147L_NDM, showed that it carried sequences from KpVP-1, (the dominant virulence plasmid type found in K1-ST23 hypervirulent isolates such as NTUH K2044 (AP006726.1)) (40% coverage), an IncFII tra-trb conjugative transfer region and transposons carrying antibiotic resistance genes. The presence of multiple transposons and insertion sequences was a consistent finding for all the isolates described here; for example, there are seven (plus a truncated version) copies of IS26-like insertion sequences in pKpvST383, six in pKpvST147L, and four in pKpvST101 (as defined by comparison with nucleotides 1–717 of KU984333). It therefore seems likely that these hybrid plasmids have been created by IS-mediated recombination. It is important to recognise the existence of hybrid virulence and resistance plasmids, so that an antibiotic is not chosen inadvertently that selects for isolates carrying virulence plasmids. The combination of an NDM gene and virulence elements in the same plasmid, as seen in KpvST383_NDM_OXA-48, Kpv_ST383_S1 and KpvST48_NDM is particularly alarming. In several cases described here, the clinical outcome was clearly consistent with enhanced virulence, in contrast to that described previously where the isolate (KpvST147L_NDM) was from a rectal screen. Another study describing carbapenemase-gene-positive representatives of ST15 carrying a virulence plasmid (of approximately 178 kb and carrying rmpA2 and the iutAiucABCD aerobactin gene cluster) found that the isolates were not hypervirulent based on assays looking for survival in neutrophils and killing of Galleria mellonella and that all the affected patients recovered [17]. The authors concluded that further studies were needed to understand the relationship between the hypervirulent phenotype, carriage of the pLVPK-like virulence plasmid and capsular type. However, representatives of ST11 carrying a virulence plasmid showed enhanced survival in neutrophils and killed 100% of G. mellonella; these isolates were responsible for fatal infections, and the authors concluded that the hypervirulence was due to acquisition of a 170 kb pLVPK-like virulence plasmid by classic ST11 carbapenem-resistant K. pneumoniae strains [8]. Another study links three glycosyltransferases encoded by the cps gene cluster, GT-1, GT-2 and WcaJ, with virulence [18]. We note the presence of wcaJ (and glycosyltransferases) in the cps gene cluster of KpvST383_NDM_OXA-48 and KpvST147B_SE1_1_NDM, but not in those of KpvST48_NDM, Kpv_ST15_NDM or KpvST101_OXA-48.
While some of the hybrid resistance/virulence plasmids described here were similar, each ST was nevertheless associated with a different plasmid, suggesting that there is an IS-mediated mechanism for combining these genes in these plasmids. In one instance there was clearly a shared antibiotic resistance region in the virulence/resistance plasmids of isolates of different types (STs 383 and ST48), again supporting IS-mediated recombination. The existence of hybrid virulence and resistance plasmids requires enhanced surveillance, especially since it is occurring in high-risk clones that are already adept at acquiring resistance genes, if potentially untreatable invasive infections are to be avoided.
4. Materials and Methods
Isolates were submitted to the laboratory from hospitals in the United Kingdom for typing and cross-infection investigation, and/or susceptibility determination. They were identified as potentially hypervirulent by detection of rmpA and/or rmpA2 in a multiplex PCR seeking capsular types K1, K2, K5, K20, K54 and K57, rmpA, rmpA2 and wcaG, among other targets [9]. Typing was by Variable Number Tandem Repeat (VNTR) analysis at 11 loci [9], while detection of carbapenemase genes was carried out in-house by the submitting hospital. Representative isolates that were PCR-positive for rmpA/rmpA2, belonged to high-risk clones (identified by VNTR typing) and in which a carbapenemase gene(s) had been detected were selected for this study. Isolates were sequenced on a minION Mk1B, following DNA extraction using a GeneJet genomic DNA kit (ThermoFisher, Loughborough, United Kingdom) and library preparation using a Rapid Barcoding Kit SQK-RBK004 (Oxford Nanopore Technologies, Oxford, United Kingdom). The barcoded libraries of up to nine isolates were pooled, concentrated using Ampure XP beads (Beckman Coulter, High Wycombe, United Kingdom) and run on a FLO-MIN106 (R9 version) flowcell using minKnow software with local basecalling. Barcodes were identified and removed using Guppy barcode software available from Oxford Nanopore technologies and reads for each barcode assembled using miniasm 0.2-r168-dirty [19], followed by three iterations of correction with Racon 1.3.1 [20]. Illumina sequencing was also carried out on six isolates, as described previously, and the short-read sequences used to correct the minION assemblies using ten iterations of Racon. Sequences were submitted to GenBank under BioProject PRJNA483246 and BioSamples SAMN09729079 (KpvST101_OXA-48) (accession numbers CP031368-CP031375), SAMN10409888 (KpvST383_NDM_OXA-48) (accession numbers CP034200-CP034202), SAMN11793480 (KpvST48_NDM) (accession numbers VCEE00000000; CM016731-CM016736), SAMN11793565 (KpvST15_NDM) (accession numbers CP040593-CP04599) and SAMN11835544 (KpvST147B_SE1_1_NDM) (accession numbers CP040724-CP040731). The minION fastq files of all the remaining isolates (and the Illumina fastqs, where available) were submitted to the Sequence Read Archive (SRA) accession numbers SAMN12212724 (KpvST101_SE2_2), SAMN12216748 (Kpv_ST101_L5), SAMN12216749 (Kpv_ST147_SE1_2), SAMN12216750 (Kpv_ST147_L3), SAMN12221326 (Kpv_ST383_L2), SAMN12221327 (Kpv_ST383_S1) and SAMN12221328 (Kpv_ST15_NW1). Although greater than 99% accurate, the minION sequences have some additional/missing bases and therefore are not completely accurate, but have the huge advantage of facilitating complete assemblies. Virulence plasmids were compared with that of a previously described isolate of ST147 (KpvST147L_NDM) (CM007852) and with that in NTUH-K2044, a representative of “hypervirulent” K1-ST23 (AP006726). Sizes of plasmids were confirmed by pulsed-field gel electrophoresis (PFGE), as described by Barton et al. [21], following digestion of agarose-embedded DNA plugs in 100 µL 1 × S1 nuclease buffer containing 0.1 U/µL S1 nuclease (Thermofisher, Loughborough, United Kingdom) (Figure S1). PFGE conditions were 6 V/cm for 30 h at 12 °C, with initial and final switch times of 1 s and 50 s.
MICs were determined by agar dilution and interpreted using EUCAST breakpoints [15]. Resistance genes and plasmid replicon types were detected using ResFinder and PlasmidFinder, respectively, on the Center for Genomic Epidemiology website [22,23]. Sequence types were determined from the Pasteur Institute Klebsiella pneumoniae MLST website (available online: https://bigsdb.pasteur.fr/cgi-bin/bigsdb/bigsdb.pl?db=pubmlst_klebsiella_seqdef&page=sequenceQuery).
Acknowledgments
We are grateful to colleagues in hospital laboratories for referring these isolates and to the Genomic Services and Development Unit at PHE for carrying out Illumina sequencing.
Supplementary Materials
Supplementary materials can be found at https://www.mdpi.com/2076-2607/7/9/326/s1.
Author Contributions
Conceptualization, J.T. (Jane Turton); Formal analysis, J.T. (Jack Turton); Investigation, J.T. (Jane Turton), F.D., C.P., Z.P. and R.P.; Writing—original draft, J.T. (Jane Turton); Writing—review & editing, F.D., J.T. (Jack Turton), C.P., Z.P. and R.P.
Funding
No specific funding was received for this work. Typing, detection of virulence genes and susceptibility determinations were carried out as part of the routine work of the laboratory.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Gomez-Simmonds A., Uhlemann A.C. Clinical implications of genomic adaptation and evolution of carbapenem-resistant Klebsiella pneumoniae. J. Infect. Dis. 2017;215:S18–S27. doi: 10.1093/infdis/jiw378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Holt K.E., Wertheim H., Zadoks R.N., Baker S., Whitehouse C.A., Dance D., Jenney A., Connor T.R., Hsu L.Y., Severin J., et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc. Natl. Acad. Sci. USA. 2015;112:E3574–E3581. doi: 10.1073/pnas.1501049112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Shon A.S., Bajwa R.P., Russo T.A. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: A new and dangerous breed. Virulence. 2013;4:107–118. doi: 10.4161/viru.22718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Lee C.R., Lee J.H., Park K.S., Jeon J.H., Kim Y.B., Cha C.J., Jeong B.C., Lee S.H. Antimicrobial resistance of hypervirulent Klebsiella pneumoniae: Epidemiology, hypervirulence-associated determinants, and resistance mechanisms. Front. Cell. Infect. Microbiol. 2017;7:483. doi: 10.3389/fcimb.2017.00483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Roulston K.J., Bharucha T., Turton J.F., Hopkins K.L., Mack D.J.F. A case of NDM-carbapenemase producing hypervirulent Klebsiella pneumoniae Sequence Type 23 from the United Kingdom. JMM Case Rep. 2018;5:e005130. doi: 10.1099/jmmcr.0.005130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Becker L., Kaase M., Pfeifer Y., Fuchs S., Reuss A., von Laer A., Sin M.A., Korte-Berwanger M., Gatermann S., Werner G. Genome-based analysis of carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008–2014. Antimicrob. Resist. Infect. Control. 2018;7:62. doi: 10.1186/s13756-018-0352-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Andrade L.N., Vitali L., Gaspar G.G., Bellissimo-Rodrigues F., Martinez R., Darini A.L. Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone. J. Clin. Microbiol. 2014;52:2530–2535. doi: 10.1128/JCM.00088-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gu D., Dong N., Zheng Z., Lin D., Huang M., Wang L., Chan E.W., Shu L., Yu J., Zhang R., et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: A molecular epidemiological study. Lancet Infect. Dis. 2018;18:37–46. doi: 10.1016/S1473-3099(17)30489-9. [DOI] [PubMed] [Google Scholar]
- 9.Turton J.F., Payne Z., Coward A., Hopkins K.L., Turton J.A., Doumith M., Woodford N. Virulence genes in isolates of Klebsiella pneumoniae from the UK during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and ‘non-hypervirulent’ types ST147, ST15 and ST383. J. Med. Microbiol. 2018;67:118–128. doi: 10.1099/jmm.0.000653. [DOI] [PubMed] [Google Scholar]
- 10.Huang Y.H., Chou S.H., Liang S.W., Ni C.E., Lin Y.T., Huang Y.W., Yang T.C. Emergence of an XDR and carbapenemase-producing hypervirulent Klebsiella pneumoniae strain in Taiwan. J. Antimicrob. Chemother. 2018;73:2039–2046. doi: 10.1093/jac/dky164. [DOI] [PubMed] [Google Scholar]
- 11.Lam M.M.C., Wyres K.L., Wick R.R., Judd L.M., Fostervold A., Holt K.E., Löhr I.H. Convergence of virulence and MDR in a single plasmid vector in MDR Klebsiella pneumoniae ST15. J. Antimicrob. Chemother. 2019;74:1218–1222. doi: 10.1093/jac/dkz028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dong N., Lin D., Zhang R., Chan E.W., Chen S. Carriage of blaKPC-2 by a virulence plasmid in hypervirulent Klebsiella pneumoniae. J. Antimicrob. Chemother. 2018;73:3317–3321. doi: 10.1093/jac/dky358. [DOI] [PubMed] [Google Scholar]
- 13.Lery L.M., Frangeul L., Tomas A., Passet V., Almeida A.S., Bialek-Davenet S., Barbe V., Bengoechea J.A., Sansonetti P., Brisse S., et al. Comparative analysis of Klebsiella pneumoniae genomes identifies a phospholipase D family protein as a novel virulence factor. BMC Biology. 2014;12:41. doi: 10.1186/1741-7007-12-41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Sullivan M.J., Petty N.K., Beatson S.A. Easyfig: A genome comparison visualizer. Bioinformatics. 2011;27:1009–1010. doi: 10.1093/bioinformatics/btr039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.European Committee on Antimicrobial Susceptibility Testing: Clinical Breakpoints. [(accessed on 2 September 2019)]; Available online: http://www.eucast.org/clinical_breakpoints/
- 16.Lam M.M.C., Wyres K.L., Judd L.M., Wick R.R., Jenney A., Brisse S., Holt K.E. Tracking key virulence loci encoding aerobactin and salmochelin siderophore synthesis in Klebsiella pneumoniae. Genome Med. 2018;10:77. doi: 10.1186/s13073-018-0587-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Shu L., Dong N., Lu J., Zheng Z., Hu J., Zeng W., Sun Q., Chan E.W., Zhou H., Hu F., et al. Emergence of OXA-232 carbapenemase-producing Klebsiella pneumoniae that carries a pLVPK-like virulence plasmid among elderly patients in China. Antimicrob. Agents Chemother. 2019;3:e02246-18. doi: 10.1128/AAC.02246-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Cai R., Wang G., Le S., Wu M., Cheng M., Guo Z., Ji Y., Xi H., Zhao C., Wang X., et al. Three capsular polysaccharide synthesis-related glucosyltransferases, GT-1, GT-2 and WcaJ, are associated with virulence and phage sensitivity of Klebsiella pneumoniae. Front. Microbiol. 2019;10:1189. doi: 10.3389/fmicb.2019.01189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Li H. Minimap and miniasm: Fast mapping and de novo assembly for noisy long sequences. Bioinformatics. 2016;32:2103–2110. doi: 10.1093/bioinformatics/btw152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Vaser R., Sović I., Nagarajan N., Šikić M. Fast and accurate de novo genome assembly from long uncorrected reads. Genome Res. 2017;27:737–746. doi: 10.1101/gr.214270.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Barton B.M., Harding G.P., Zuccarelli A.J. A General Method for Detecting and Sizing Large Plasmids. Anal. Biochem. 1995;226:235–240. doi: 10.1006/abio.1995.1220. [DOI] [PubMed] [Google Scholar]
- 22.Zankari E., Hasman H., Cosentino S., Vestergaard M., Rasmussen S., Lund O., Aarestrup F.M., Larsen M.V. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 2012;67:2640–2644. doi: 10.1093/jac/dks261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Carattoli A., Zankari E., Garcia-Fernandez A., Voldby Larsen M., Lund O., Villa L., Aarestrup F.M., Hasman H. PlasmidFinder and pMLST: In silico detection and typing of plasmids. Antimicrob. Agents Chemother. 2014;58:3895–3903. doi: 10.1128/AAC.02412-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.